Clinical Trial Update: MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A mesenchymal stem cell-derived exosome therapy is being studied in Phase 1/2 trials for endothelial dysfunction associated with preeclampsia, including postpar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• MSC exosome therapy (mesenchymal stem cell-derived exosomes)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Preeclampsia, Postpartum | Phase 1, Phase 2 | Status: RECRUITING